ABIVAX (EPA:ABVX) | Finanzwire

Basculer en Français

10053	Companies
205214	Keywords
135462	Articles
108806	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 05/08/2024 at 08:30, 1 year 10 months ago

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024. The event will showcase new data on obefazimod's impact and mechanism of action

Abivax Obefazimod Ulcerative Colitis Colon Cancer Digestive Disease Week 2024
BRIEF

published on 05/07/2024 at 22:05, 1 year 10 months ago

Abivax Announces Availability of Documents for Upcoming General Meeting

Biotechnology Shareholder Information Corporate Governance Abivax General Meeting
PRESS RELEASE

published on 05/07/2024 at 22:00, 1 year 10 months ago

Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents
Abivax informs shareholders of its ordinary and extraordinary general meeting on May 30, 2024, providing access to preparatory documents and details on participation. Obefazimod and Abivax information included

Abivax Obefazimod General Meeting Clinical-stage Biotechnology Preparatory Documents
PRESS RELEASE

published on 05/07/2024 at 22:00, 1 year 10 months ago

Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents
Abivax announces its annual ordinary and extraordinary general meeting on May 30, 2024, with preparatory documents available for shareholders. The meeting details, including agenda and resolutions, are accessible on the company's website

Shareholders Biotechnology Abivax General Meeting Preparatory Documents
BRIEF

published on 04/30/2024 at 18:05, 1 year 10 months ago

ABIVAX reports the number of shares and voting rights as of March 31, 2024

Share Capital Voting Rights Financial Markets Authority Abivax Regulatory Information
BRIEF

published on 04/05/2024 at 22:05, 1 year 11 months ago

Abivax Announces Submission of Financial Reports to French and U.S. Regulatory Agencies

Abivax Financial Reports Chronic Inflammatory Diseases Regulatory Agencies Webcast Announcement
PRESS RELEASE

published on 04/05/2024 at 22:00, 1 year 11 months ago

Abivax publishes financial reports with the French and U.S. securities regulatory agencies
Abivax publishes 2023 financial reports with French and U.S. securities regulators, including annual report and governance information

Abivax Financial Reports Regulatory Agencies French Securities U.S. Securities
BRIEF

published on 04/02/2024 at 08:35, 1 year 11 months ago

Abivax Reports 2023 Financial Results and Operational Update

Financial Results Abivax Obefazimod Ulcerative Colitis Nasdaq IPO
PRESS RELEASE

published on 04/02/2024 at 08:30, 1 year 11 months ago

Abivax reports 2023 financial results and operational update
Abivax reports 2023 financial results & operational update. Raised EUR 500M, aims to finance operations till Q4 2025. Webcast on April 8, 2024

Financial Results Fundraising Abivax Webcast Operational Update
BRIEF

published on 03/27/2024 at 18:05, 1 year 11 months ago

ABIVAX publishes its number of shares and voting rights as of February 29, 2024

Euronext Paris Share Capital Voting Rights Abivax Regulation

Accesswire

Published on 03/19/2026 at 07:30, 3 hours 4 minutes ago

Tocvan Drone Magnetic Data Strengthens Gold-Silver Targets Across Gran Pilar; Identifies Broad Zones for Expansion Potential
Published on 03/19/2026 at 06:35, 3 hours 59 minutes ago

Golden Lake Announces Securityholder Approval of Arrangement with McEwen Inc.
Published on 03/19/2026 at 01:05, 9 hours 29 minutes ago

Prospect Ridge Announces Closing of Flow-Through Share Private Placement
Published on 03/18/2026 at 23:45, 10 hours 49 minutes ago

Orogen Royalties Announces Private Placement Update
Published on 03/18/2026 at 21:00, 13 hours 34 minutes ago

PLDT's Smart Selects Amdocs to Transform Retail Operations with AI-Powered Store Genie

View all ACCESSWIRE

EQS Group

Published on 03/19/2026 at 10:14, 19 minutes ago

Pentixapharm Holding AG will publish its financial report for the 2025 fiscal year on March 26, 2026
Published on 03/19/2026 at 10:05, 28 minutes ago

Shipsy Launches AgentFleet, an AI Workforce for Logistics Operations
Published on 03/19/2026 at 10:05, 29 minutes ago

Villeroy & Boch successfully holds its own in the 2025 financial year despite challenging market conditions
Published on 03/19/2026 at 10:00, 33 minutes ago

Original-Research: Finexity AG (von GBC AG): BUY
Published on 03/19/2026 at 09:30, 1 hour 4 minutes ago

DN Group AG: First International Impact Forum 2026 in Monaco focused on Circular & Blue Economy

Les Echos

Published on 03/19/2026 at 08:45, 1 hour 49 minutes ago

Deezer and Sonos renew and expand long-term collaboration
Published on 03/19/2026 at 07:00, 3 hours 34 minutes ago

bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
Published on 03/19/2026 at 07:00, 3 hours 34 minutes ago

2025 Annual results and new strategic signature
Published on 03/18/2026 at 19:41, 14 hours 52 minutes ago

Covivio - Conditions of availability of the 2025 Universal Registration Document
Published on 03/18/2026 at 18:00, 16 hours 34 minutes ago

Deezer achieves profitability in FY25 as strategy delivers tangible results

View all LES ECHOS COMFI WIRE